{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:46:27Z","timestamp":1794638787883,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ningxia Key Technology Achievement Transformation Project","award":["2024CJE09005"],"award-info":[{"award-number":["2024CJE09005"]}]},{"name":"Ningxia Natural Science Foundation Key Project","award":["2024AAC02066"],"award-info":[{"award-number":["2024AAC02066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04910-6","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T08:48:09Z","timestamp":1751532489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Associations of cardiovascular-kidney-metabolic conditions with all-cause and cardiovascular mortality among US adults: a population-based cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Songfeng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"4910_CR1","doi-asserted-by":"crossref","unstructured":"Jw O, et al. Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999\u20132020. JAMA Cardiol. 2023;8.","DOI":"10.1001\/jamacardio.2023.3241"},{"key":"4910_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, et al. Cardiovascular-Kidney-Metabolic health: A presidential advisory from the American heart association. Circulation. 2023;148:1606\u201335.","journal-title":"Circulation"},{"key":"4910_CR3","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the American heart association. Circulation. 2019;139:e840\u201378.","journal-title":"Circulation"},{"key":"4910_CR4","doi-asserted-by":"publisher","first-page":"e44073","DOI":"10.2196\/44073","volume":"9","author":"W Li","year":"2023","unstructured":"Li W, et al. Association between metabolic syndrome and mortality: prospective cohort study. JMIR Public Health Surveill. 2023;9:e44073.","journal-title":"JMIR Public Health Surveill"},{"key":"4910_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ijcard.2016.03.210","volume":"214","author":"N Fang","year":"2016","unstructured":"Fang N, Jiang M, Fan Y. Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality: A meta-analysis. Int J Cardiol. 2016;214:279\u201383.","journal-title":"Int J Cardiol"},{"key":"4910_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ckj\/sfac218","volume":"16","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the global burden of disease study 2019. Clin Kidney J. 2023;16:312\u201321.","journal-title":"Clin Kidney J"},{"key":"4910_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1053\/j.ajkd.2005.05.027","volume":"46","author":"UD Patel","year":"2005","unstructured":"Patel UD, Young EW, Ojo AO, Hayward RA. CKD progression and mortality among older patients with diabetes. Am J Kidney Dis Off J Natl Kidney Found. 2005;46:406\u201314.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"4910_CR8","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.cpcardiol.2023.102344","volume":"49","author":"SA Sebastian","year":"2024","unstructured":"Sebastian SA, Padda I, Johal G. Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review. Curr Probl Cardiol. 2024;49:102344.","journal-title":"Curr Probl Cardiol"},{"key":"4910_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"Emerging Risk Factors Collaboration","year":"2015","unstructured":"Emerging Risk Factors Collaboration. Association of cardiometabolic Multimorbidity with mortality. JAMA. 2015;314:52\u201360.","journal-title":"JAMA"},{"key":"4910_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12916-021-02126-x","volume":"19","author":"D Canoy","year":"2021","unstructured":"Canoy D, et al. Association between cardiometabolic disease Multimorbidity and all-cause mortality in 2 million women and men registered in UK general practices. BMC Med. 2021;19:258.","journal-title":"BMC Med"},{"key":"4910_CR11","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.2337\/dc22-0717","volume":"45","author":"T Geng","year":"2022","unstructured":"Geng T, et al. Associations of New-Onset atrial fibrillation with risks of cardiovascular disease, chronic kidney disease, and mortality among patients with type 2 diabetes. Diabetes Care. 2022;45:2422\u20139.","journal-title":"Diabetes Care"},{"key":"4910_CR12","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jchf.2023.05.015","volume":"11","author":"JW Ostrominski","year":"2023","unstructured":"Ostrominski JW, et al. Cardio-Renal-Metabolic overlap, outcomes, and Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. JACC Heart Fail. 2023;11:1491\u2013503.","journal-title":"JACC Heart Fail"},{"key":"4910_CR13","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2022","unstructured":"ElSayed NA, et al. 2. Classification and diagnosis of diabetes: standards of care in Diabetes\u20142023. Diabetes Care. 2022;46:S19\u201340.","journal-title":"Diabetes Care"},{"key":"4910_CR14","doi-asserted-by":"publisher","first-page":"1066219","DOI":"10.3389\/fcvm.2022.1066219","volume":"9","author":"S Zhao","year":"2023","unstructured":"Zhao S, et al. Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension. Front Cardiovasc Med. 2023;9:1066219.","journal-title":"Front Cardiovasc Med"},{"key":"4910_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease","year":"2021","unstructured":"Kidney Disease. Improving global outcomes (KDIGO) glomerular diseases work group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100:S1\u2013276.","journal-title":"Kidney Int"},{"key":"4910_CR16","doi-asserted-by":"publisher","first-page":"e034996","DOI":"10.1161\/JAHA.124.034996","volume":"13","author":"J Li","year":"2024","unstructured":"Li J, et al. Social risk profile and Cardiovascular-Kidney\u2010Metabolic syndrome in US adults. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2024;13:e034996.","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"key":"4910_CR17","doi-asserted-by":"publisher","first-page":"e2238361","DOI":"10.1001\/jamanetworkopen.2022.38361","volume":"5","author":"JJ Joseph","year":"2022","unstructured":"Joseph JJ, et al. Associations of cardiometabolic Multimorbidity with All-Cause and coronary heart disease mortality among black adults in the Jackson heart study. JAMA Netw Open. 2022;5:e2238361.","journal-title":"JAMA Netw Open"},{"key":"4910_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ki.2008.645","volume":"75","author":"R de Mutsert","year":"2009","unstructured":"de Mutsert R, Jager KJ, Zoccali C, Dekker FW. The effect of joint exposures: examining the presence of interaction. Kidney Int. 2009;75:677\u201381.","journal-title":"Kidney Int"},{"key":"4910_CR19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/ije\/dym157","volume":"36","author":"MJ Knol","year":"2007","unstructured":"Knol MJ, van der Tweel I, Grobbee DE, Numans ME, Geerlings M. I. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007;36:1111\u20138.","journal-title":"Int J Epidemiol"},{"key":"4910_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/CM9.0000000000001985","volume":"135","author":"J Fan","year":"2022","unstructured":"Fan J, et al. Multimorbidity patterns and association with mortality in 0.5 million Chinese adults. Chin Med J (Engl). 2022;135:648\u201357.","journal-title":"Chin Med J (Engl)"},{"key":"4910_CR21","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod MN, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389:1069\u201384.","journal-title":"N Engl J Med"},{"key":"4910_CR22","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.2215\/CJN.18641120","volume":"16","author":"FC Brosius","year":"2021","unstructured":"Brosius FC, et al. Transforming the care of patients with diabetic kidney disease. Clin J Am Soc Nephrol CJASN. 2021;16:1590\u2013600.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"4910_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/healthcare12070753","volume":"12","author":"N Tecce","year":"2024","unstructured":"Tecce N, et al. Harnessing the synergy of SGLT2 inhibitors and continuous ketone monitoring (CKM) in managing heart failure among patients with type 1 diabetes. Healthcare. 2024;12:753.","journal-title":"Healthcare"},{"key":"4910_CR24","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380:2295\u2013306.","journal-title":"N Engl J Med"},{"key":"4910_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"WG Herrington","year":"2023","unstructured":"Herrington WG, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388:117\u201327.","journal-title":"N Engl J Med"},{"key":"4910_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/kidneydial4040016","volume":"4","author":"A Cersosimo","year":"2024","unstructured":"Cersosimo A, Drera A, Adamo M, Metra M, Vizzardi E. Exploring the cardiorenal benefits of SGLT2i: A comprehensive review. Kidney Dial. 2024;4:184\u2013202.","journal-title":"Kidney Dial"},{"key":"4910_CR27","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436\u201346.","journal-title":"N Engl J Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04910-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04910-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04910-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T08:48:12Z","timestamp":1751532492000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04910-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4910"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04910-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocols of NHANES were approved by the NCHS ethnic review board. All participants have signed the written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"443"}}